glp-1-receptoragonister GLP-1 Receptor Agonists: The New Wave in Diabetes Management Frontiers | GLP-1 Receptor Agonists:

Unfortunately, the current trend is completely the opposite, with a steady increase in overweight and obesity affecting the youngest, putting them at very high risk of developing a veritable epidemic of cardiometabolic diseases in a few years (see our article on this subject)

Therefore DIO mice were treated daily with escalating doses of P5 or equimolar doses of Ex4 for 4 weeks

So this is, for so many reasons, a very complicated issue to think about, which I think makes it very interesting.

Pathogens 10 , 152 (2021)

GLP-1RA use was associated with a reduction in depression, suggesting that GLP-1RA could potentially be considered an antidepressant therapy